About

Publication thumbnail: Efficacy and safety of upadacitinib or elsubrutinib alone or in combination for systemic lupus erythematosus:  A Phase 2 randomized controlled trial

Efficacy and safety of upadacitinib or elsubrutinib alone or in combination for systemic lupus erythematosus: A Phase 2 randomized controlled trial

Publication thumbnail: Urinary soluble CD163 is useful as "liquid biopsy" marker in  lupus nephritis at both diagnosis and follow-up to predict  impending flares

Urinary soluble CD163 is useful as "liquid biopsy" marker in lupus nephritis at both diagnosis and follow-up to predict impending flares

Publication thumbnail: Immunosuppressives discontinuation after renal response in lupus nephritis: predictors of flares, time to withdrawal and long-term outcomes

Immunosuppressives discontinuation after renal response in lupus nephritis: predictors of flares, time to withdrawal and long-term outcomes

Publication thumbnail: Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study

Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study

Steering Committee